Red Door Wealth Management’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCY
IAIM
Red Door Wealth Management's ONCY Position: Q3 2021 in Review
Red Door Wealth Management sold out of Oncolytics Biotech (ONCY) in Q3 2021, closing a stake of 1,000 shares — an estimated $2K sold.
Red Door Wealth Management first reported a position in ONCY in Q2 2021 and held it in 1 quarter. The position peaked at $2K in Q2 2021. 37 funds tracked by Wall St. Rank hold ONCY as of Q3 2021.
- Red Door Wealth Management reported no remaining Oncolytics Biotech position as of Q3 2021 after selling out during the quarter.
- Red Door Wealth Management sold 1,000 Oncolytics Biotech shares in Q3 2021, an estimated $2K.
- Red Door Wealth Management first reported a position in Oncolytics Biotech in Q2 2021 and held it in 1 quarter.
- Red Door Wealth Management's Oncolytics Biotech position peaked at $2K in Q2 2021.
- 37 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2021.
Based on Red Door Wealth Management's 13F filing for Q3 2021, filed 14 Oct 2021.